CHICAGO, Sept. 20,
2023 /PRNewswire/ -- Ispire Technology Inc. ("Ispire"
or the "Company") (NASDAQ: ISPR), a leader in vapor technology, is
thrilled to announce its attendance and participation at the
upcoming Benzinga Cannabis Capital Conference. The event is
scheduled for September 27-28, 2023,
at the Chicago Marriott Downtown Magnificent Mile.
Main Highlights
- Co-Chief Executive Officer Michael
Wang and Chief Financial Officer Daniel Machock will be available for interviews
and to field inquiries from the press.
- Private 1-on-1 meetings with potential investors and industry
stakeholders are scheduled.
- Ispire will be prominently displayed in the exhibition
hall.
Spotlight on Ispire ONE™
Visitors to the Ispire booth can expect:
- Newly introduced Ispire ONETM vaporizer devices,
including all-in-one disposables, cartridges, and pod systems.
- The Ispire ONETM filling machine, aimed at enhancing
operational efficiency in manufacturing and co-packing
processes.
"Our participation at the Benzinga Cannabis Capital Conference
signifies an important moment for Ispire. We will be unmistakably
visible, taking a central role in showcasing the innovative Ispire
ONE™ technology," said Michael Wang,
Co-Chief Executive Officer of Ispire. "This is an ideal platform to
elevate our brand and assert our position as a major player in the
industry."
Investor Engagement
Interested parties are encouraged to schedule private
discussions, interviews, or seek additional information by
contacting Investor Relations at ir@ispiretechnology.com.
About Ispire Technology Inc.
Ispire is engaged in the research and developmetnt, design,
commercialization, sales, marketing, and distribution of branded
e-cigarettes and cannabis vaping products. The Company's operating
subsidiaries own or license from a related party more than 200
patents received or filed globally. Ispire's tobacco products are
marketed under the Aspire brand name and are sold worldwide (except
in the United States, the People's Republic of China, and
Russia) primarily through our
distribution network. Ispire's cannabis products are marketed under
the Ispire brand name primarily on an original design manufacturer
(ODM) basis to other cannabis vapor companies. Ispire currently
sells its cannabis vaping hardware only in the United States, and it recently commenced
marketing activities in Canada and
Europe, primarily in the European
Union.
Please visit www.ispiretechnology.com and follow us on Facebook,
Twitter, Instagram, Linkedin, Pinterest, and YouTube. Any
information contained on, or that can be accessed through, the
Company's website, any other website or any social media, is not a
part of this press release.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended ("Securities Act") as well as Section 21E of the Securities
Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995, as amended, that are intended to be
covered by the safe harbor created by those sections.
Forward-looking statements, which are based on certain assumptions
and describe the Company's future plans, strategies and
expectations, can generally be identified by the use of
forward-looking terms such as "believe," "expect," "may," "will,"
"should," "would," "could," "seek," "intend," "plan," "goal,"
"project," "estimate," "anticipate," "strategy," "future," "likely"
or other comparable terms, although not all forward-looking
statements contain these identifying words. All statements other
than statements of historical facts included in this press release
regarding the Company's strategies, prospects, financial condition,
operations, costs, plans and objectives are forward-looking
statements. Important factors that could cause the Company's actual
results and financial condition to differ materially from those
indicated in the forward-looking statements. Such forward-looking
statements include, but are not limited to, risks and uncertainties
including those regarding: the Company's business strategies, the
ability of the Company to market to the Ispire ONETM,
Ispire ONETM's success if meeting its goals, the ability
of its customers to derive the anticipated benefits of the Ispire
ONETM and the success of their products on the markets;
the Ispire ONETM proving to be safe, and the risk and
uncertainties described in "Risk Factors," "Management's Discussion
and Analysis of Financial Condition and Results of Operations,"
"Cautionary Note on Forward-Looking Statements" and the additional
risk described in Ispire's Form 10-K annual report for the year
ended June 30, 2023 and any
subsequent filings which Ispire makes with the Securities and
Exchange Commission. You should not rely upon forward-looking
statements as predictions of future events. The forward-looking
statements made in the press release relate only to events or
information as of the date on which the statements are made in the
press release. We undertake no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, after the date on which the statements
are made or to reflect the occurrence of unanticipated events
except as required by law. You should read this press release with
the understanding that our actual future results may be materially
different from what we expect.
Contact
For more information, kindly contact:
Investor Relations
Sherry Zheng
718.213.7386
ir@ispiretechnology.com
View original
content:https://www.prnewswire.com/news-releases/ispire-technology-inc-to-exhibit-and-present-at-benzinga-cannabis-capital-conference-301932434.html
SOURCE Ispire Technology Inc.